Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
17.87
+0.07 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Avanos Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Avanos Medical.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Avanos Medical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 |
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +39.90% | Jun 21, 2023 |
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +73.48% | May 22, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +45.50% | May 4, 2023 |
Financial Forecast
Revenue This Year
699.14M
from 673.30M
Increased by 3.84%
Revenue Next Year
727.40M
from 699.14M
Increased by 4.04%
EPS This Year
1.35
from -1.33
EPS Next Year
1.70
from 1.35
Increased by 26.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 720.2M | 756.8M | 807.4M |
| Avg | 699.1M | 727.4M | 777.4M |
| Low | 671.3M | 694.4M | 740.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 7.0% | 8.3% | 11.0% |
| Avg | 3.8% | 4.0% | 6.9% |
| Low | -0.3% | -0.7% | 1.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.40 | 1.89 | 2.13 | |
| Avg | 1.35 | 1.70 | 2.07 | |
| Low | 1.28 | 1.57 | 1.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 40.5% | 25.4% | |
| Avg | - | 26.4% | 21.8% | |
| Low | - | 16.6% | 17.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.